In the fight against cancer, new and more specific targets are needed. Here we offer an example of a potential target that has not been widely studied, namely, the syncytin protein. Syncytin is expressed mainly in the human placenta and is implicated in placental syncytiotrophoblast cell fusion. Not much is known about the role of syncytin in cancer, but the existing data call for more intense research. Its retroviral origins and particular tissue distribution make syncytin an interesting potential target in cancer therapy.
Further information:
Related posts:
- Hemorrhage of brain metastasis from non-small cell lung cancer post gefitinib therapy: two case reports and review of the literature
- ChromoCure Completes Realignment of Management as First Step in Transition to Cancer Therapy and Cure Research & Development
- Potential contribution of aspirin to cancer control programmes
- ChromoCure Rebrands Corporate Image and Realigns Operations to Reflect Its Pioneering Role in Cancer Detection, Therapy and Cure
- Genome-wide gene copy number and expression analysis of primary gastric tumors and gastric cancer cell lines
Posted in